180 related articles for article (PubMed ID: 17599090)
21. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo.
Katiyar SK; Meeran SM; Katiyar N; Akhtar S
Mol Carcinog; 2009 Jan; 48(1):24-37. PubMed ID: 18459128
[TBL] [Abstract][Full Text] [Related]
22. p53 alone or in combination with antisense cyclin D1 induces apoptosis and reduces tumor size in human melanoma.
Sauter ER; Takemoto R; Litwin S; Herlyn M
Cancer Gene Ther; 2002 Oct; 9(10):807-12. PubMed ID: 12224020
[TBL] [Abstract][Full Text] [Related]
23. Altered subcellular localization and low frequency of mutations of ING1 in human brain tumors.
Vieyra D; Senger DL; Toyama T; Muzik H; Brasher PM; Johnston RN; Riabowol K; Forsyth PA
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5952-61. PubMed ID: 14676120
[TBL] [Abstract][Full Text] [Related]
24. Targeting malignant gliomas with a glial fibrillary acidic protein (GFAP)-selective oncolytic adenovirus.
Horst Mt; Brouwer E; Verwijnen S; Rodijk M; de Jong M; Hoeben R; de Leeuw B; Smitt PS
J Gene Med; 2007 Dec; 9(12):1071-9. PubMed ID: 17902184
[TBL] [Abstract][Full Text] [Related]
25. PCTAIRE3: a putative mediator of growth arrest and death induced by CTS-1, a dominant-positive p53-derived synthetic tumor suppressor, in human malignant glioma cells.
Naumann U; Huang H; Wolburg H; Wischhusen J; Weit S; Ohgaki H; Weller M
Cancer Gene Ther; 2006 May; 13(5):469-78. PubMed ID: 16276348
[TBL] [Abstract][Full Text] [Related]
26. Oncolytic activity of p53-expressing conditionally replicative adenovirus AdDelta24-p53 against human malignant glioma.
Geoerger B; Vassal G; Opolon P; Dirven CM; Morizet J; Laudani L; Grill J; Giaccone G; Vandertop WP; Gerritsen WR; van Beusechem VW
Cancer Res; 2004 Aug; 64(16):5753-9. PubMed ID: 15313916
[TBL] [Abstract][Full Text] [Related]
27. Fiber-knob modifications enhance adenoviral tropism and gene transfer in malignant glioma.
Zheng S; Ulasov IV; Han Y; Tyler MA; Zhu ZB; Lesniak MS
J Gene Med; 2007 Mar; 9(3):151-60. PubMed ID: 17351980
[TBL] [Abstract][Full Text] [Related]
28. Enhanced radiosensitivity of malignant glioma cells after adenoviral p53 transduction.
Broaddus WC; Liu Y; Steele LL; Gillies GT; Lin PS; Loudon WG; Valerie K; Schmidt-Ullrich RK; Fillmore HL
J Neurosurg; 1999 Dec; 91(6):997-1004. PubMed ID: 10584846
[TBL] [Abstract][Full Text] [Related]
29. Growth inhibition efficacy of an adenovirus expressing dual therapeutic genes, wild-type p53, and anti-erbB2 ribozyme, against human bladder cancer cells.
Irie A; Matsumoto K; Anderegg B; Kuruma H; Kashani-Sabet M; Scanlon KJ; Uchida T; Baba S
Cancer Gene Ther; 2006 Mar; 13(3):298-305. PubMed ID: 16110311
[TBL] [Abstract][Full Text] [Related]
30. Effects of Gamma Knife surgery on C6 glioma in combination with adenoviral p53 in vitro and in vivo.
Xu D; Jia Q; Li Y; Kang C; Pu P
J Neurosurg; 2006 Dec; 105 Suppl():208-13. PubMed ID: 18503358
[TBL] [Abstract][Full Text] [Related]
31. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.
Kim SM; Lim JY; Park SI; Jeong CH; Oh JH; Jeong M; Oh W; Park SH; Sung YC; Jeun SS
Cancer Res; 2008 Dec; 68(23):9614-23. PubMed ID: 19047138
[TBL] [Abstract][Full Text] [Related]
32. Interaction between p53 and p16 expressed by adenoviral vectors in human malignant glioma cell lines.
Kim SK; Wang KC; Cho BK; Chung HT; Kim YY; Lim SY; Lee CT; Kim HJ
J Neurosurg; 2002 Jul; 97(1):143-50. PubMed ID: 12134905
[TBL] [Abstract][Full Text] [Related]
33. Combination gene therapy with p53 and Thoc1/p84 is more effective than either single agent in an animal model of human pancreatic adenocarcinoma.
Yin S; Goodrich DW
Int J Oncol; 2006 Mar; 28(3):781-5. PubMed ID: 16465385
[TBL] [Abstract][Full Text] [Related]
34. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
Song Y; Shen K; Yu JR
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307
[TBL] [Abstract][Full Text] [Related]
35. Cyclosporine a induces growth arrest or programmed cell death of human glioma cells.
Zupanska A; Dziembowska M; Ellert-Miklaszewska A; Gaweda-Walerych K; Kaminska B
Neurochem Int; 2005 Nov; 47(6):430-41. PubMed ID: 16087277
[TBL] [Abstract][Full Text] [Related]
36. p53 enhances the Delta-24 conditionally replicative adenovirus anti-glioma effect.
Mitlianga PG; Sioka C; Vartholomatos G; Goussia A; Polyzoidis K; Rao JS; Kyritsis AP
Oncol Rep; 2006 Jan; 15(1):149-53. PubMed ID: 16328048
[TBL] [Abstract][Full Text] [Related]
37. Reduced transduction efficiency of adenoviral vectors expressing human p53 gene by repeated transduction into glioma cells in vitro.
Yamamoto S; Yoshida Y; Aoyagi M; Ohno K; Hirakawa K; Hamada H
Clin Cancer Res; 2002 Mar; 8(3):913-21. PubMed ID: 11895926
[TBL] [Abstract][Full Text] [Related]
38. Adenoviral p53 gene transfer inhibits human Tenon's capsule fibroblast proliferation.
Johnson KT; Rödicker F; Heise K; Heinz C; Steuhl KP; Pützer BM; Hudde T
Br J Ophthalmol; 2005 Apr; 89(4):508-12. PubMed ID: 15774934
[TBL] [Abstract][Full Text] [Related]
39. Sox11 prevents tumorigenesis of glioma-initiating cells by inducing neuronal differentiation.
Hide T; Takezaki T; Nakatani Y; Nakamura H; Kuratsu J; Kondo T
Cancer Res; 2009 Oct; 69(20):7953-9. PubMed ID: 19808959
[TBL] [Abstract][Full Text] [Related]
40. An oncolytic adenoviral vector carrying the tyrosinase promoter for glioma gene therapy.
Ulasov IV; Rivera AA; Nettelbeck DM; Rivera LB; Mathis JM; Sonabend AM; Tyler M; Wang M; Douglas JT; Lesniak MS
Int J Oncol; 2007 Nov; 31(5):1177-85. PubMed ID: 17912445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
